UCB has announced that Norman J. Ornstein is a candidate to be appointed to its Board of Directors on 24 April 2008.
Mr Ornstein is a resident scholar at the American Enterprise Institute in Washington D.C. and an expert in the workings of the US Congress. He holds a PhD in political science from the University of Michigan and an Honorary Doctor of Laws from the University of Minnesota.
Based in Brussels, Belgium, UCB develops therapies for CNS disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology.
Source
UCB press release, 28 March 2008
Copyright 2008 Evernow Publishing Ltd